Exhibit 16.1

                               February 10, 2005

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549


RE: China Biopharmaceuticals Holdings, INC.
    FILE REF. NO. 814-00063

We were  previously  the  principal  accountants  for  China  Biopharmaceuticals
Holdings,  Inc (Formerly Globus Growth Group Inc.) for the period from September
9, 2004  through  February  8, 2005.  On February 8, 2005,  our  appointment  as
principal  accountants  was  terminated.  We have read China  Biopharmaceuticals
Holdings,  Inc.'s  statements  included  under  Item  4.01 of its Form 8-K dated
February 10,  2005,  and we agree with the  statements  made in response to that
Item insofar as they relate to our Firm.



                                                    Very truly yours,


                                                     /s/WEINBERG & COMPANY, P.A.
                                                    ----------------------------
                                                    WEINBERG & COMPANY, P.A.
                                                    Certified Public Accountants